Modeling receptor flexibility in the structure-based design of KRAS(G12C) inhibitors.
Modeling receptor flexibility in the structure-based design of KRAS(G12C) inhibitors.
复制标题
DOI:
10.1007/s10822-022-00467-0
复制
发表时间:
2022-08
影响因子:
3.5
通讯作者:
中科院分区:
文献类型:
--
作者:
KRAS has long been referred to as an ‘undruggable’ target due to its high affinity for its cognate ligands (GDP and GTP) and its lack of readily exploited allosteric binding pockets. Recent progress in the development of covalent inhibitors of KRASG12C has revealed that occupancy of an allosteric binding site located between the α3-helix and switch-II loop of KRASG12C—sometimes referred to as the ‘switch-II pocket’—holds great potential in the design of direct inhibitors of KRASG12C. In studying diverse switch-II pocket binders during the development of sotorasib (AMG 510), the first FDA-approved inhibitor of KRASG12C, we found the dramatic conformational flexibility of the switch-II pocket posing significant challenges toward the structure-based design of inhibitors. Here, we present our computational approaches for dealing with receptor flexibility in the prediction of ligand binding pose and binding affinity. For binding pose prediction, we modified the covalent docking program CovDock to allow for protein conformational mobility. This new docking approach, termed as FlexCovDock, improves success rates from 55 to 89% for binding pose prediction on a dataset of 10 cross-docking cases and has been prospectively validated across diverse ligand chemotypes. For binding affinity prediction, we found standard free energy perturbation (FEP) methods could not adequately handle the significant conformational change of the switch-II loop. We developed a new computational strategy to accelerate conformational transitions through the use of targeted protein mutations. Using this methodology, the mean unsigned error (MUE) of binding affinity prediction were reduced from 1.44 to 0.89 kcal/mol on a set of 14 compounds. These approaches were of significant use in facilitating the structure-based design of KRASG12C inhibitors and are anticipated to be of further use in the design of covalent (and noncovalent) inhibitors of other conformationally labile protein targets. The online version contains supplementary material available at 10.1007/s10822-022-00467-0.
登录
查看更多内容
影响因子:
3.7
作者:
Grant, Barry J.;Lukman, Suryani;Gorfe, Alemayehu A.
通讯作者:
Gorfe, Alemayehu A.
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
7.3
作者:
Fell, Jay B.;Fischer, John P.;Marx, Matthew A.
通讯作者:
Marx, Matthew A.
影响因子:
7.3
作者:
Lanman, Brian A.;Allen, Jennifer R.;Cee, Victor J.
通讯作者:
Cee, Victor J.
DOI:
10.1073/pnas.2106195118
发表时间:
2021-09-07
影响因子:
11.1
作者:
Kamenik, Anna S.;Singh, Isha;Shoichet, Brian K.
通讯作者:
Shoichet, Brian K.